QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.081232v1 313/2/740    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alkondon, M. Articles by Albuquerque, E. X. Search for Related Content PubMed PubMed Citation Articles by Alkondon, M. Articles by Albuquerque, E. X.

NEUROPHARMACOLOGY

Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by Bupropion

Department of Pharmacology and Experimental Therapeutics (M.A., E.X.A.), University of Maryland School of Medicine, Baltimore, Maryland; and Departamento de Farmacologia Básica e Clínica (E.X.A.), Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

To identify the brain nicotinic acetylcholine receptor (nAChR) subtypes that may be involved in nicotine addiction, we investigated the actions of bupropion, a drug used in cigarette smoking cessation programs, and nicotine on three pharmacologically identified nAChRs in rat hippocampal slices, namely, type IA, type II, and type III nAChRs, likely representing 7, 42, and 34 subunits, respectively. Using whole-cell patch-clamp recordings from interneurons of acute hippocampal slices prepared from male rat pups, we studied the effect of nicotine on in vivo up-regulation and in vitro desensitization of nAChRs. Two subcutaneous injections of nicotine (0.586 mg/kg free base, in less than a day) to rats at postnatal days 14 to 15 significantly enhanced the magnitude of functional responses arising from type III and type II, but not type IA nAChRs. This treatment did not increase the functional affinity for acetylcholine at type II nAChRs. A single injection of nicotine also produced a significant increase in type III nAChR response. In addition, type III and type II, but not type IA nAChRs, are desensitized by in vitro exposure to nicotine at concentrations found in the venous blood of cigarette smokers. Bupropion at 1 µM produced 56, 15, and 0% inhibition of type III, type II, and type IA nAChR responses, respectively, in the slices. Our results suggest that in vivo-nicotine-induced nAChR up-regulation observed in neurons of intact brain tissue is a physiologically relevant phenomenon and that early up-regulation of type III and type II nAChRs could be an important biological signal in nicotine addiction.

Address correspondence to: Dr. Manickavasagom Alkondon, Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201. E-mail: malko001{at}umaryland.edu

This article has been cited by other articles:

				E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function Physiol Rev, January 1, 2009; 89(1): 73 - 120. [Abstract] [Full Text] [PDF]

				M. Alkondon, Y. Aracava, E. F. R. Pereira, and E. X. Albuquerque A Single in Vivo Application of Cholinesterase Inhibitors Has Neuron Type-Specific Effects on Nicotinic Receptor Activity in Guinea Pig Hippocampus J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 69 - 82. [Abstract] [Full Text] [PDF]

				R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S. R. Grady, P. Whiteaker, Q. Huang, T. McClure-Begley, J. M. Lindstrom, C. Labarca, et al. Chronic Nicotine Cell Specifically Upregulates Functional {alpha}4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path J. Neurosci., August 1, 2007; 27(31): 8202 - 8218. [Abstract] [Full Text] [PDF]

				D. S. McGehee Nicotinic and Opioid Receptor Interactions in Nicotine Addiction Mol. Interv., December 1, 2006; 6(6): 311 - 314. [Abstract] [Full Text] [PDF]

				M. Alkondon and E. X. Albuquerque Subtype-Specific Inhibition of Nicotinic Acetylcholine Receptors by Choline: A Regulatory Pathway J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 268 - 275. [Abstract] [Full Text] [PDF]

				G. R. Abdrakhmanova, M. I. Damaj, F. I. Carroll, and B. R. Martin 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine Is a Novel Potent Competitive Antagonist of Human Neuronal {alpha}4beta2 nAChRs Mol. Pharmacol., June 1, 2006; 69(6): 1945 - 1952. [Abstract] [Full Text] [PDF]